Selected News & Events

Stealth BioTherapeutics Enters into Exclusive Licensing Agreement with Pharmanovia to Commercialize Elamipretide for the Treatment of Barth Syndrome in Europe and Key Global Territories

Press Release / May 30, 2023June 3, 2024

Stealth BioTherapeutics Presents at the 2023 JMP Securities Life Sciences Conference

Event / May 15, 2023May 16, 2023

Stealth BioTherapeutics to Present Overview of Elamipretide Clinical Development Program in Barth Syndrome at the 2023 American College of Medical Genetics Meeting

Press Release / March 9, 2023June 3, 2024

Stealth BioTherapeutics Announces SBT-272 Data Updates and Orphan Drug Designation for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

Press Release / November 1, 2022June 3, 2024

Stealth BioTherapeutics to Participate in Upcoming Ultra-Rare Disease Events

Press Release / September 15, 2022June 3, 2024

Events Calendar

No events listed at this time.

@StealthBT on Twitter

StealthBT Follow

We’re driven by a desire to help those with mitochondrial dysfunction, leading mitochondrial medicine for both rare and common diseases. https://t.co/45rgM9EXLN

Retweet on Twitter StealthBT Retweeted

MitoAction @mitoaction ·

3 Jan

We are just a week away from the 2025 Mito Town Meeting. We have so many wonderful people from our mito community coming to present on what they accomplished in 2024 and what they have in store for 2025. Register on our website to join us next Friday! https://buff.ly/3Dmerec

Reply on Twitter 1875270995155571018 Retweet on Twitter 1875270995155571018 1 Like on Twitter 1875270995155571018 X 1875270995155571018

StealthBT @stealthbt ·

23 Dec

In this holiday season, we cherish the connections we've made, the milestones we've achieved together, and the excitement of what's yet to come. May your holidays be filled with joy, & the New Year bring opportunities and continued progress. Happy Holidays from the Stealth team!

Reply on Twitter 1871199550633066977 Retweet on Twitter 1871199550633066977 Like on Twitter 1871199550633066977 1 X 1871199550633066977

StealthBT @stealthbt ·

20 Dec

#DidYouKnow: We’re conducting a clinical study in dry age-related macular degeneration, a leading cause of blindness. Learn more about the ReNEW Phase 3 trial: https://dry-amdclinicaltrials.com/
#dryAMD

Reply on Twitter 1870135463488442531 Retweet on Twitter 1870135463488442531 Like on Twitter 1870135463488442531 X 1870135463488442531

StealthBT @stealthbt ·

10 Dec

#BarthSyndrome is a #RareDisease that affects the muscles, and can lead to serious heart problems, debilitating fatigue, lack of appetite, growth delays, and more. It impacts all aspects of life. To learn more about this condition, listen to Abe’s story.

Reply on Twitter 1866550409076281500 Retweet on Twitter 1866550409076281500 Like on Twitter 1866550409076281500 2 X 1866550409076281500

Contact Us

Stealth BioTherapeutics

275 Grove Street, Suite 3-107
Newton, MA 02466
(617) 600-6888
info@stealthbt.com

Media Inquiries

media@stealthbt.com

Investor Inquiries

IR@stealthbt.com